Invescent
Sep 30, 6:41 AM
NEWS AFTER MARKET CLOSE
$VNDA — 6:45 PM ET Positive Phase 3 results. Trial met its primary endpoint. FDA submission planned.
$DBVT — 6:28 PM ET Submitted BLA to the FDA for VIASKIN Peanut Patch. Priority Review requested.
$DYN — 4:05 PM ET New one year Phase 1/2 clinical data released.
$CAPR — New 24 month deramiocel data. Shares moved roughly 20% after hours.
$TLX — FDA Fast Track designation for its BiPASS prostate cancer imaging program.
Stocks to watch heading into premarket.
$VNDA $DBVT $DYN $CAPR $TLX
